November 2010 Supplement - Endovascular Today

Table of Contents

Supplement

November 2010 Supplement

The Future of Aortic Therapy

Key ares of ongoing global study regarding the expanding applicability of aortic endovascular repair.

Issue

Thoracic Catastrophes

Reports on the benefits and pitfalls of endovascular options for challenging thoracic aortic pathologies.

View Issue

Download PDF

Introduction

Next-Generation Devices for TEVAR

The Valiant Stent Graft: 30-day results from the VALOR II study.

By Ronald M. Fairman, MD

Valiant Captivia Postmarket Registry

Preliminary results from the multicenter, postmarket, noninterventional, prospective study.

By Rossella Fattori, MD

The VIRTUE Registry

The VIRTUE registry is designed to assess thoracic endografting with the Valiant Stent Graft System for the treatment of type B aortic dissections.

By Matt Thompson, MD, FRCS

Extending TEVAR Therapy

Two new trials for US indications for descending thoracic aortic dissections and traumatic transections.

By Rodney A. White, MD

Breaking Barriers: Expanding the EVAR Population

The new technology and techniques that will allow operators to treat a higher-risk subset of patients.

By Giovanni Torsello, MD, PhD, and Konstantinos Donas, MD, PhD

The ENGAGE Study

The 30-day results from the first 180 patients enrolled.

By Vincent Riambau, MD, PhD, and Dittmar Bockler, MD, PhD, on Behalf of the Engage Investigators

Quality Imaging With 3D CTA for Aortic Endovascular Therapies

A look at why three-dimensional preprocedural imaging is important for managing complex aortic cases.

By Douglas Massop, MD, FACS

Latest Issues

April 2026

March 2026

February 2026

January 2026

December 2025

View All Issues